Medical records received ad 07 jan 2020 were reviewed on 09 jan 2020 by a clinician to identify patient harms/product issues.Primary operative notes (b)(6) 2012 indicate the patient received a right total hip replacement with 1-stage femoral shortening due to crowe iv congenitally dislocated hip.A femoral bone fragment was generated and then secured by cerclage wire for bone grafting.Doi: (b)(6) 2012, dor: no revision reported, (right hip).
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed, and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
|